daratumumab,pomalidomide,ciltacabtagene autoleucel,dexamethasone,bortezomib
janssen
['congrat', 'cartitude', 'cartitude-4']
congratulations to on his great presentation of the cartitude-4 oral presentation at #eha2023! #mycompany 
VP of Oncology Global Medical Affairs at Janssen, J&J

Scientist focused on bringing new treatment options for pts with cancer. Tweets/views shared are my own